SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Claris Lifesciences settles its litigations and license agreement for generic DIPRIVAN in USA

20 Apr 2015 Evaluate

Claris Lifesciences (Claris) has reached a settlement and license agreement, ending all pending litigation with Fresenius Kabi USA, Inc with reference to the alleged infringement of a patent relating to Propofol for Injection, 10 mg/ml, which is a generic version of DIPRIVAN.

Under the terms of the settlement and license agreement, Claris and Claris Lifesciences Inc (USA) has been granted approval to sell its generic version of Propofol for Injection beginning October 15, 2016, prior to the June 1, 2025 expiry of the patent that formed the basis of the litigation.  According to IMS health data as of June 2014, Propofol Injection had an annual market size of approximately US$ 251 million in the USA.

Claris manufactures and markets products across multiple delivery systems, markets, and therapeutic segments including anesthesia, blood products, anti-infectives, and plasma volume expanders. A significant majority of these products are generic drugs that are capable of being directly injected into the human body, which are predominantly used in the treatment of critical illnesses.

Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×